Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Amolyt Pharma
company
About
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €1.80M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical,Therapeutics,Wellness
- Founded date
- Jan 1, 2007
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€131.80M $80M
Amolyt Pharma has raised a total of
€131.80M $80M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2023 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2023 | Series C | €130M | 1 | — | — | Detail |
| Sep 16, 2021 | Series B | $80M | 1 | — | — | Detail |
| Mar 17, 2015 | Series Unknown | €1.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Amolyt Pharma is funded by 1 investors.
Credit Agricole Entreprises
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Credit Agricole Entreprises
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
